Clinical Development,Clinical Operations,Precision and Personalised Medicine

Personalised Medicine Strategies – Providing More Clinical Benefit

7 months ago By Ben Parkes
  • Share on

  • Facebook
  • Linkedin

Current personalised medicine strategies provide limited clinical benefit – how do we do better?

Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here’s another chance to watch his fascinating keynote presentation, packed full of fresh insights, data and takeaways.

The next chance to here the latest clinical insights, including more on personalised medicine strategies, will be at our clinical Online Strategy Meetings in November. For more information check out the links below:

Clinical Operations Strategy Meeting – November 16
Clinical Trial Supply Chain Strategy Meeting – November 18
Pharmacovigilance Strategy Meeting – November 19

More news

Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

3 days ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine

Weekly News Round-up – 5/3/21

In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...

3 days ago

Data Capture, Integration and Storage in Decentralised Trials

Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...

1 week ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine

Data Capture, Integration and Storage in Decentralised Trials

Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...

1 week ago

Weekly News Round-up – 26/2/21

In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...

1 week ago
Clinical Development,Clinical Operations,Precision and Personalised Medicine

Weekly News Round-up – 26/2/21

In the news this week, Moderna is set to make a profit for the first time with huge profit expectations for 2021. In other news, Icon acquires PRA for $12 billion to create a ‘mega-CRO’, and the first variant of...

1 week ago
Working With us

Interested?
Reserve your space